Anschutz Health Sciences Building. Photo courtesy of ZGF Architects © Connie Zhou

University of Colorado Anschutz
Cancer Center
Scientific Retreat

Friday, November 20th, 2026

University of Colorado Anschutz

At the Don Elliman Conference Center, located on the 2nd floor of the Anschutz Health Science Building (AHSB)

18900 N Revere Ct, Aurora, CO


Advance Career Research

Shape Strategic Vision

Turn Discovery Into Impact


Featuring Keynote Speaker

Razelle Kurzrock, MD, FACP

Director of the Center for Precision Oncology and Rare Cancers, Professor of Medicine and Chair of Precision Oncology, Medical College of Wisconsin Cancer Center

Shared Content Block:
Cancer Center Styles -- Give headings inside accordions and tabs more top margin

Coming soon!

2026 Cancer Center Scientific Retreat Speakers

Featured Speaker

blonde researcher in a white coat

Razelle Kurzrock, MD, FACP

Director of the Center for Precision Oncology and Rare Cancers, Professor of Medicine and Chair of Precision Oncology, Medical College of Wisconsin Cancer Center

Dr. Kurzrock is a world-renowned leader in precision oncology and research on rare cancers. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair of the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading to the FDA approval of eight life-changing drugs. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work.

 

Call for Abstracts

You and members of your lab are invited to submit abstracts for consideration for oral and poster presentations at the University of Colorado Cancer Center’s Scientific Retreat on November 20, 2026.

This event brings together investigators, trainees, clinicians, and research staff to highlight scientific advances, spark new collaborations, and align our collective work with the Cancer Center’s strategic priorities.

Retreat Theme: Advancing Our Strategic Vision

This year’s retreat is structured around the latest scientific advances made by Cancer Center members and how the Center’s strategic plan aligns with research being conducted in members’ labs.

The Cancer Center’s strategic plan emphasizes five core scientific foci:

1. Structural, Molecular, and Cellular Biology

Investigate chromatin biology, epigenetic regulation, and genome stability | Define mechanisms governing telomer function and genome integrity | Develop RNA-based approaches for understanding and treating cancer

2. Cancer Evolution from Initiation through Metastatic Spread

Characterize the molecular mechanisms underlying cancer initiation and cell fate decisions | Identify pathways driving tumor progression and metastatic spread | Determine how aging, obesity, hormones, and other host factors influence cancer evolution

3. Therapeutic Resistance

Identify mechanisms of resistance to cancer therapies | Develop novel therapeutic strategies to prevent or overcome treatment resistance | Translate discoveries into improved therapies or catchment area priority cancers

4. Immunotherapy

Define how the tumor microenvironment and host factors regulate anti-tumor immunity | Harness immunomodulators and the microbiome to enhance immune responses | Engineer next-generation cellular immunotherapies

5. Cancer Interception and Survivorship

Develop and investigate new interception targets | Design behavioral, supportive and palliative care interventions to improve survivorship | Leverage health services and implementation science approaches to improve equitable cancer care delivery

 

Abstracts should reflect one or more of these strategic areas, with priority given to work that demonstrates:

Recent new scientific impact or innovation

Cross program collaborations

Advances in translational potential

Innovation in efforts to address unmet clinical or population needs 

Leverage of Cancer Center supported shared resources and emerging technologies

Submitted abstracts will be considered for mainroom oral presentations, concurrent targeted discussion sessions, and the poster session.

 

Abstract Submission Guidelines

Abstract length: 30 line maximum (based on an 8.5x11 page with ½ margins)

Format: Background, Methods, Results, Conclusions (or equivalent for early‑stage projects).

Eligibility: Full, Mentored, Affiliate, and Clinical Cancer Center members along with the trainees, fellows, and research staff working in Cancer Center member labs/research programs.

Abstract Submission


Important Dates

Abstract submission deadline: September 14, 2026, 5:00 pm

Notification of acceptance: October 21, 2026

Retreat date: November 20, 2026

 

 

 

New This Year: Keynote Panel DiscussionFuture of Cancer Clinical Trials

Our Keynote Speaker is Razelle Kurzrock, MD, FACP 
Google Scholar | N-of-1 Patient Centric Clinical Trials

Following the keynote address, we will host an expanded panel discussion featuring Dr. Kurzrock, clinical trial leaders, and others engaged in driving laboratory research into human applications through investigator-initiated clinical trials.

To enrich this session and ensure it reflects the interests of our research community, we invite retreat participants to submit questions for the panel.

Questions should be limited to the panel discussion topic: Future of Cancer Clinical Trials.

Some topic areas to consider:

  • Barriers and opportunities in clinical trial design or accrual

  • Translational pathways from discovery to implementation

  • Emerging technologies or methodologies

  • Broader issues in cancer research strategy and collaboration

More info to come

Conference Location

The conference will held be at the University of Colorado Anschutz in Aurora, Colorado, in the Don Elliman Conference Center, located on the 2nd floor of Anschutz Health Science Building (AHSB).

Conference Parking

Parking will be available for all attendees in the Vail, Breckenridge, Snowmass or Aspen lots.

Conference Entrance

Enter the building through the west entrance. From past the security desk, you will make a left to take the elevator to the second floor. If you want to take the stairs, after the security desk, make a right and use the main staircase.

CMS Login